Taho Pharmaceuticals Ltd. (TPE:6467)
204.00
-20.50 (-9.13%)
At close: Nov 19, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 10.69 billion as of November 19, 2026. It is the 16,980th most valuable company in the world and the 610th biggest in Taiwan. Its market cap has increased by 21.31% in one year.
Market Cap
10.69B
Enterprise Value
10.45B
Revenue
6.26M
Global Rank
Country Rank
#610 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 10.69B, an increase of 411.54%. That is a compound annual growth rate of 14.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 10.69B | 86.58% |
| Dec 31, 2025 | 5.73B | 151.98% |
| Dec 31, 2024 | 2.27B | 1,107.48% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 6.10B |
| TEH SENG Pharmaceutical Mfg. | 2.48B |
| Protect Animal Health | 1.93B |
| Libo Pharma | 1.72B |
| Timing Pharmaceutial | 1.71B |
| Anbogen Therapeutics | 1.69B |
| Gin Hwa Biotech Incorporation | 1.26B |
| TSA International | 1.17B |